Recce progresses testing of gel to treat bacterial skin infections
Recce Pharmaceuticals Ltd has reached an important milestone in testing of its R327G gel to treat bacterial skin infections
POU
0.43%
$21.06
BETASHARES BRITISH POUND ETF - Corporate Spotlight
Currently unlisted.
Add to my watchlist
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
No Corporate Spotlight currently available.